Specialist developer, investor and manager of real estate Arrow Capital Partners has completed the sale of Arrow Point Crawley development for £25 million.
Developed by Arrow in 2022 for its Strategic Industrial Real Estate (SIRE) joint venture with Cerberus Capital Management, the Arrow Point Crawley logistics development was sold to a fund managed by Aberdeen Investments.
Arrow Point Crawley comprises two units totalling 83,883ft² that are fully leased to two occupiers on long-term leases, with a WAULT of more than seven years.
The units are occupied by Blueleaf Limited, the UK’s largest independent care home supplier, and Leo Cancer Care Ltd, a medical technology company.
Arrow Point provides high quality mid-box accommodation built to an institutional specification, and offers excellent sustainability credentials including an EPC rating of ‘A’ and a BREEAM ‘Very Good’ certification.
Katherine Parker, partner and head of investment management, Europe at Arrow Capital Partners, said: “This sale completes our business plan for Arrow Point Crawley.
“We’ve taken the asset from development to full occupancy, securing two long-term occupiers, and ultimately selling it to an institutional core investor.
“The sale demonstrates continued demand for high quality assets with strong sustainability credentials in core locations.
“The team is actively looking to acquire logistics development sites in strategic hubs throughout Europe, as it continues to implement its global development and leasing programmes.”
